I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. Japan: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatch/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako


List of Tables

Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. Japan: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment

Table 3. Japan: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. Japan: Western Blot/Other Confirmatory Tests Volume and Sales Forecast
by Market Segment
Table 5. Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. Japan: AIDS Diagnostics Market by Major Supplier
Table 7. Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers